Document is current
Any future updates will be listed below
-
Authors
Okholm, Trine Line Hauge https://orcid.org/0000-0002-2779-4029
Sathe, Shashank
Park, Samuel S.
Kamstrup, Andreas Bjerregaard
Rasmussen, Asta Mannstaedt
Shankar, Archana
Chua, Zong Ming
Fristrup, Niels
Nielsen, Morten Muhlig
Vang, Søren
Dyrskjøt, Lars
Aigner, Stefan
Damgaard, Christian Kroun
Yeo, Gene W.
Pedersen, Jakob Skou
-
Funding
Funding for this research was provided by:
Lundbeckfonden (#R191-2015-1515, R296-2018-2094)
Kræftens Bekæmpelse (R124-A 7869-15-82, R167-A11105, R215-A12954, R204-A12270)
Sundhed og Sygdom, Det Frie Forskningsråd (DFF - 7016-00379)
Harboefonden (19110, 18004)
Aage og Johanne Louis-Hansens Fond (19-2B-5030)
Familien Hede Nielsens Fond
Sundhedsvidenskabelige Fakultet, Aarhus Universitet
NEYE Fonden
- License Information
-
More Information
Article History
Received: 29 March 2020
Accepted: 12 November 2020
First Online: 7 December 2020
Ethics approval and consent to participate
: Informed written consent to take part in future research projects was obtained from all patients, and the specific project was approved by the National Committee on Health Research Ethics (#1708266). The research conforms to the principles of the Helsinki Declaration.
: Not applicable.
: GWY is cofounder, member of the Board of Directors, on the SAB, equity holder, and paid consultant for Locanabio and Eclipse BioInnovations. GWY is a visiting professor at the National University of Singapore. GWY’s interests have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. The remaining authors declare no competing interests.
